![](https://investorshub.advfn.com/uicon/170585.png?cb=1715106542)
Sunday, October 11, 2009 8:20:16 PM
Most curious that no one has countered my last argument (other than personal attacks) as to why the value of the purported phramaceutical market is not there for BEHL. It's not even in their ballpark. Speaks volumes people.
I am sitting here wondering if they even know that it takes FDA approved tubing for instance( I am thinking of their super secret tubing formula they have trusted the Chinese with, who are not know for protecting IP) for the bioreactor, and everything else in contact with the product?
That takes tons of money for product development, extensive testing and QA/QC process development and testing for FDA approval if it is going into a pharmaceutical drug, and still takes major work even for a food ingredient.
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM